Veru Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Veru Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 87% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-169.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 87% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -78%In 3 years sales changed by -100% while total assets changed by -78%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-39.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 68% of Healthcare companies in United States.
Cash Cushion Ratio
+39%Cash, after subtracting all debt, equals 39% of its market value (net cash).
Higher than 74% of Healthcare companies in United States.
Tangible Assets Ratio
77%Of every $100 the company owns, $77 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 55% of Healthcare companies in United States.
Tangible Net Worth Ratio
62%Of every $100 of net worth, $62 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 53% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Veru Inc. made a loss over the last year. Veru Inc. owes $0.23 for every $1 it owns. Veru Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
LossVeru Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.35The share price is 1.35 times Veru Inc.'s book value per share, lower than 71% of Healthcare companies in United States.
Market cap
$38 MThe total market value of all of Veru Inc.'s shares at today's price (share price × number of shares), smaller than 76% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$28 MWhat Veru Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.66Net worth divided by the number of shares. The share price of $2.24 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
-64.5%Veru Inc. lost 64.5% of its shareholders' money over the last year, lower than 59% of Healthcare companies in United States.
Owes vs Owns
0.23×Veru Inc. owes $0.23 for every $1 it owns (low), lower than 68% of Healthcare companies in United States.
Dividend yield
NoneVeru Inc. does not currently pay a dividend.
Profit growth
LossVeru Inc. made a loss in each of the last two years.
Cash vs debt
Net cashVeru Inc. held $15 M more cash than debt (net cash) at Sep 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Veru Inc.: $38 M ÷ $28 M (30 Jun 2026) = 1.3.
What is Veru Inc.'s return on equity?
Veru Inc. lost 64.5% of its shareholders' money over the last year, lower than 59% of Healthcare companies in United States.
How much does Veru Inc. owe compared with what it owns?
Veru Inc. owes $0.23 for every $1 it owns (low), lower than 68% of Healthcare companies in United States.
Does Veru Inc. pay a dividend?
No. Veru Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.